CLL Society Inc. Profile picture
The CLL Society is a 501(c)(3) formed to help meet the unmet needs of those living with #CLL and #SLL. https://t.co/PMtovq27vV
Aug 21, 2021 5 tweets 4 min read
BREAKING NEWS: Today AstraZeneca released results of the AZD7442 PROVENT Phase III pre-exposure prophylaxis trial. This is the first trial to show significant effectiveness of monoclonal antibodies in pre-exposure protection against #COVID19 in a high-risk population. The study showed a 77% reduction in the development of symptomatic #COVID19. One-time shots are expected to provide 6-12 months of protection.